Park Medi World Completes Zirakpur Hospital Acquisition, Announces Q1 Financial Results and Expansion Plans
Park Medi World Ltd has finalized the acquisition of 'Mehar Hospital-Zirakpur,' signaling a deepening commitment to healthcare presence in the Tricity region. The company also released its unaudited financial results for the quarter ended June 30, 2026, alongside other significant operational updates concerning its network expansion and corporate structure.The acquisition of Mehar Hospital-Zirakpur from Mehar Mediserve LLP was finalized in an all-cash transaction valued at INR 107 Crores. This strategic move aligns with the Group's objective of achieving economies of scale and maximizing operational synergies through asset deployment in high potential markets. 'Mehar Hospital,' which possesses a capacity of 150+ beds, is a well-established multi-super speciality institution serving Zirakpur and the wider Tricity catchment area.
The transaction marked a phase completion in Park Medi World’s regional strengthening strategy. The company successfully acquired an 80% shareholding in V3 Healthcare Private Limited, which operates "The Medicity Hospital - Rudrapur" (a multi-super speciality hospital with 330 beds), on July 31, 2026. The remaining 20% of the stake is scheduled for acquisition by April 30, 2030, with an approximate cost of 71,770 millions for the entire acquisition.
Financial Performance Highlights (Quarter Ended June 30, 2026)
The Board of Directors approved the unaudited consolidated and standalone financial results for the quarter ended June 30, 2026. The company continues to expand its footprint and operational capacity across various states in North India.Park Medi World reported strong consolidated performance during the quarter. Total income stood at 4,833.55 million, while revenue from operations reached 4,757.09 million. Profit after tax for the consolidated entity was reported at 885.93 million, resulting in Earnings Per Share (EPS) of 2.05.
The unaudited standalone financial results showed a Total Income figure of 335.32 million. The company recorded a profit after tax of 10.84 million for the quarter, with an EPS reported at 0.03.
Key figures from both consolidated and standalone performance are detailed below:
| Metric | Standalone (Q ended June 30, 2026) | Consolidated (Q ended June 30, 2026) |
|---|---|---|
| Total Income | 335.32 Million | 4,833.55 Million |
| Profit after Tax | 10.84 Million | 885.93 Million |
| EPS (Basic) | 0.03 | 2.05 |
Operational Updates and Growth Strategy
In addition to the Zirakpur acquisition, Park Medi World continues to execute a robust growth strategy across its facilities:- New Hospital Launch: The company launched a 350 bedded advanced multi-super specialty hospital in Panchkula on April 10, 2026. This facility is equipped with advanced diagnostics and modular operation theatres.
- Capacity Expansion: Umkal Healthcare Private Limited, a wholly owned subsidiary, proposed the expansion of its existing 225-beded Park Hospital in Palam Vihar, Gurugram, adding 100 new beds. The expanded facility will be branded as "Park Hospital Platinum," with completion targeted for November 2026.
- Divestment: Aggarwal Hospital and Research Services Private Limited divested its 55% shareholding in Devina Derma Private Limited on June 05, 2026, receiving a consideration of 7.0 million.
The company also noted that it has one reportable business segment, "Healthcare Service," operating primarily within India and manages its operations as a single entity. The IPO proceeds utilization showed the total planned use at 7,700.00 (million), with amount utilized up to June 30, 2026 standing at 7,051.68 million.
The financial results for both standalone and consolidated entities are available on the company's website.
PARKHOSPS Stock Price Movement
Shares of Park Medi World Limited are edging higher to ₹297.50 as of 9:41 AM, rallying by 1.66% in live trading. The stock is currently holding within its intraday range, trading between a low of ₹295.25 and a high of ₹300.60.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.